BC Innovations | Mar 19, 2015
Distillery Therapeutics

Therapeutics: Ebola glycoprotein GP1; Marburg glycoprotein GP1; Niemann-Pick disease type C1 (NPC1)

Infectious disease INDICATION: Ebola virus; viral infections In vitro and mouse studies identified cross-reactive antibodies that could help treat or protect against Ebola and Marburg viral infections. NPC1 is a host factor required for viral...
Items per page:
1 - 1 of 1